Amgen places bet on heart drug as rivals go after sales

AMGEN INC. is developing a new anti-cholesterol medicine as its rivals chase after increased sales.  / BLOOMBERG FILE PHOTO
AMGEN INC. is developing a new anti-cholesterol medicine as its rivals chase after increased sales. / BLOOMBERG FILE PHOTO
SAN FRANSISCO - Amgen Inc., the world’s largest biotechnology company, is developing a new anti-cholesterol medicine by 2015 that it sees as its best shot to offset reduced sales when its popular anemia drugs lose exclusivity. Amgen, which has a facility in West Greenwich has traded at a record high by resorting to share buybacks…
To read the full story, Subscribe or
Subscribe to PBN
- Advertisement -